
Ryanair has lodged competition complaints with the German Bundeskartellamt and the European Commission (EC) regarding the “obvious conspiracy playing out in Germany between the German Government, Lufthansa and Air Berlin to carve up Air Berlin’s assets, while excluding major competitors and ignoring both EU competition and State Aid rules.”
Given the fact that the German Government is centrally involved in these maneuvers, the Bundeskartellamt is likely to struggle to be objective. On this basis, and bearing in mind the scale of the market shares and the European implications involved, it is all the more important that the EC takes immediate and decisive action.
“This manufactured insolvency is clearly being set up to allow Lufthansa to take over a debt-free Air Berlin which will be in breach of all known German and EU competition rules.
“Now even the German Government is supporting this Lufthansa-led monopoly with €150 million (US$176.7 million) of State Aid so that Lufthansa can acquire Air Berlin and drive domestic air fares in Germany even higher than they already are. German customers / visitors will suffer higher air fares to pay for this Lufthansa monopoly”, stated Ryanair’s announcement.
Full Content: Centre For Aviation
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas